Cogent Biosciences (COGT) Competitor Comparison
We are evaluating the key criteria listed to compare Cogent Biosciences (COGT) against its competitors in the Biotechnology industry.
Market Capitalization
140 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
279 / 337Free Cashflow
267 / 352Quick Ratio
114 / 357Earnings per Share
236 / 359Dividend yield
0 / 6Total Cash
119 / 358Performance 3 years
87 / 368Performance 5 years
75 / 368Performance 10 years
205 / 368Linearity 3 years
4 / 368Linearity 5 years
230 / 368Linearity 10 years
224 / 368Total Rank
89 / 368Dividend Rank
92 / 368Valuation Rank
196 / 368Piotroski Rank
198 / 368Muliplier Rank
93 / 368Linearity 10 years - COGT ranking 224 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.